期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

舒林酸对卵巢癌裸鼠腹腔移植瘤生长的影响 被引量：1

Effect of sulindac on growth of transplantable ovarian carcinoma of nude mice model
原文传递
导出
摘要 目的:探讨非甾体类消炎镇痛药舒林酸对卵巢癌裸鼠腹腔移植瘤生长的影响。方法:将卵巢癌细胞SKOV3注射于裸鼠腹腔建立卵巢癌移植瘤模型,在成瘤之前和成瘤之后两个时间段分别采用舒林酸灌胃,计算各组抑瘤率,采用RT-PCR、Western blot观察MMP-2、VEGF的表达变化。结果:舒林酸预防组对裸鼠卵巢癌生长有明显抑制作用。舒林酸预防组在mRNA和蛋白水平表达MMP-2和VEGF均显著降低。结论:早期应用舒林酸能够抑制裸鼠卵巢癌腹腔移植瘤的生长,其机制可能与降低VEGF、MMP-2表达有关。 Objective： To explore the effect of sulindac on growth of transplantable ovarian carcinoma of nude mice model. Methods ： Nude mice model of transplantable ovarian carcinoma was established by injecting ovarian carcinoma cell SKOV3 into abdominal cavity, then sulindac was used to lavage before and after tumorigenesis, the suppressive rate of carcinoma was calculated, and the expression levels of MMP - 2 and VEGF were detected by RT - PCR and Western blot. Results ： Sulindae inhibited the growth of transplantable ovarian carcinoma significantly. In sulindac prevention group, the levels of VEGF mRNA and protein, MMP - 2 mRNA and protein decreased significantly. Conclusion： Early administration of sulindac can inhibit the growth of transplantable ovarian carcinoma signifieantly, which maybe related to downregulation of MMP- 2 and VEGF.
作者 苏敏 丰有吉 黄妍 赵宇清
机构地区 南通大学附属医院妇产科 复旦大学附属妇产科医院
出处 《中国妇幼保健》 CAS 北大核心 2009年第36期5197-5199,共3页 Maternal and Child Health Care of China
基金 国家自然基金资助项目[30471806]
关键词 舒林酸 卵巢癌 MMP-2 VEGF Sulindac Ovarian carcinoma MMP - 2 VEGF
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1周蕾,于东红,王萍,承泽农.舒林酸对胃癌细胞株BGC-823作用的实验研究[J].蚌埠医学院学报,2007,32(2):132-135. 被引量：3
  • 2Yasuhisa Oida, Began Gopalan, Ryo Miyahara, et al. Sulindac enhances adenoviral vector expressing mda - 7/IL - 24 - mediated apoptosis in human lung cancer [ J] . Mol Cancer Ther, 2005, 4:291.
  • 3Lee HC, Park IC, Park MJ, et al. Sulindac and its metabolites inhibit invasion of glioblastoma cells via down - regulation of Akt/PKB and MMP-2[J]. Journal of Cellular Biochemistry, 2005, 94 (3) : 597.
  • 4Michele T, Yip- Schneider, Huangbing WU, et al. Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC - 1 is associated with cyclin D1 inhibition in vivo [ J] . Mol Cancer Ther, 2007, 6:1736.
  • 5张岩,陈颖,魏力.VEGF165与MMP2在卵巢上皮性癌中的表达及临床意义[J].医学临床研究,2008,25(11):1968-1970. 被引量：3
  • 6Yamamoto A, Yano S, Shiraga M,et al. A third -generation matrix metal- loproteinase (MMP) inhibitor ( ONO - 4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP - expressing tumor cells in nude mice [J]. Int J Cancer,2003,103 (6) : 822.

二级参考文献19

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量：1365
  • 2翟云芝,郑荣生.奥沙利铂联合亚叶酸钙、氟尿嘧啶治疗晚期胃癌[J].蚌埠医学院学报,2005,30(3):249-250. 被引量：2
  • 3Monk BJ, Choi DC, Pugmire G, et al. Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer[J]. Gynecol Oncol , 2005, 96(3) : 902-905.
  • 4Piccinno R, Puopolo M, Rigault De La Longrais IA, et al . Growth factors in epithelial ovarian cancer [J]. Minerva Ginecal , 2002,54(1) :33-52.
  • 5Harlozinska A, Sedlaczek P, Kulpa J, et al . Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma [J]. Anticancer Res , 2004,24(2c) : 1149-1157.
  • 6Lamoreaux WJ, Fitzgerald ME, Reinr A, et al . Vascular en-dothelial growth factor increases of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro[J]. Microvasc Res , 1998,55: 29-42.
  • 7Zucker S, Mirza H, Conner CE, et al . Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation[J]. Int J Cancer , 1998, 75: 780-786.
  • 8Zhang A, Meng L, Wang Q, et al . Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2[J]. Oncol Rep ,2006,15(4) : 831-836.
  • 9Ylisirnio S, Hoyhtya M, Turpeenniemi Hujanen T. Serum matrix metalloproteinases 2, -9 and tissue inhibitors of metalloprote inases-1, -2 in lung cancer TIMP-1 as a prognostic marker[J]. Anticancer Res , 2000, 20(2B):1311-1316.
  • 10Herbst RS, Yano S, Kuniyasu H, et al . Differential expression of Ecadherin and type Ⅳ collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma [J]. Clin Cancer Res , 2000, 6(3) :790-797.

共引文献4

同被引文献9

  • 1曹泽毅,主编.妇产科学[M].北京:人民卫生出版社.2008:21.
  • 2Maniotis A J, Folberg R, Hess A et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry [J] . Am JPathol, 1999, 155:739.
  • 3Scavelli C, Nico B, Cirulli T et al. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma [J] . Oncogene, 2008, 27 (5): 663.
  • 4Sun B, Zhang S, Zhang D et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma [ J ] . Oncology Reports, 2006, 16 (4) : 693.
  • 5Min Su, Liang - Qing Yao, You - Ji Feng et al. Plasticity of ovarian cancer cell and vasculogenic mimicry in vivo[J] . Int J Gynecol Cancer, 2008, 18:476.
  • 6Garimella, Phani M, Wellman et al. Cytokine regulation of HIF - 1 alpha in ovarian cancer [J] . Proceedings of the American Association for Cancer Research Annual Meeting, 2006, 47:438.
  • 7Anil KS, MaviseS, Fletcher MD et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity [ J]. Am J Obstet Gynecol, 2004, 190 (4): 899.
  • 8薛惠荣,崔满华,于晓艳.HIF-1α在卵巢上皮性肿瘤组织中的表达及意义[J].中国妇幼保健,2008,23(6):857-858. 被引量：3
  • 9韩义明,王静,王国平,敖启林.肺癌组织中血管生成拟态和HIF-1α的表达及意义[J].临床与实验病理学杂志,2008,24(3):269-272. 被引量：15

引证文献1

二级引证文献4

中国妇幼保健
2009年 第36期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部